Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1988 1
1990 1
1991 1
1994 1
1996 4
1997 1
1998 1
1999 2
2000 6
2001 4
2002 8
2003 6
2004 7
2005 14
2006 15
2007 13
2008 7
2009 9
2010 7
2011 11
2012 12
2013 10
2014 12
2015 9
2016 13
2017 11
2018 9
2019 12
2020 14
2021 10
2022 8
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Results by year

Filters applied: . Clear all
Page 1
SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma.
Ben-Josef E, Guthrie KA, El-Khoueiry AB, Corless CL, Zalupski MM, Lowy AM, Thomas CR Jr, Alberts SR, Dawson LA, Micetich KC, Thomas MB, Siegel AB, Blanke CD. Ben-Josef E, et al. Among authors: alberts sr. J Clin Oncol. 2015 Aug 20;33(24):2617-22. doi: 10.1200/JCO.2014.60.2219. Epub 2015 May 11. J Clin Oncol. 2015. PMID: 25964250 Free PMC article. Clinical Trial.
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200.
Giantonio BJ, Catalano PJ, Meropol NJ, O'Dwyer PJ, Mitchell EP, Alberts SR, Schwartz MA, Benson AB 3rd; Eastern Cooperative Oncology Group Study E3200. Giantonio BJ, et al. Among authors: alberts sr. J Clin Oncol. 2007 Apr 20;25(12):1539-44. doi: 10.1200/JCO.2006.09.6305. J Clin Oncol. 2007. PMID: 17442997 Corrected and republished. Clinical Trial.
Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials.
Gallois C, Shi Q, Meyers JP, Iveson T, Alberts SR, de Gramont A, Sobrero AF, Haller DG, Oki E, Shields AF, Goldberg RM, Kerr R, Lonardi S, Yothers G, Kelly C, Boukovinas I, Labianca R, Sinicrope FA, Souglakos I, Yoshino T, Meyerhardt JA, André T, Papamichael D, Taieb J. Gallois C, et al. Among authors: alberts sr. J Clin Oncol. 2023 Feb 1;41(4):803-815. doi: 10.1200/JCO.21.02726. Epub 2022 Oct 28. J Clin Oncol. 2023. PMID: 36306483
Mutation in BRAF V600E-Reply.
Sinicrope FA, Shi Q, Alberts SR. Sinicrope FA, et al. Among authors: alberts sr. JAMA Oncol. 2017 Sep 1;3(9):1285-1286. doi: 10.1001/jamaoncol.2017.1474. JAMA Oncol. 2017. PMID: 28617912 No abstract available.
Transplantation for hilar cholangiocarcinoma.
Heimbach JK, Haddock MG, Alberts SR, Nyberg SL, Ishitani MB, Rosen CB, Gores GJ. Heimbach JK, et al. Among authors: alberts sr. Liver Transpl. 2004 Oct;10(10 Suppl 2):S65-8. doi: 10.1002/lt.20266. Liver Transpl. 2004. PMID: 15382214 Free article. Review.
Guidelines Insights: Hepatobiliary Cancers, Version 2.2019.
Benson AB, D'Angelica MI, Abbott DE, Abrams TA, Alberts SR, Anaya DA, Anders R, Are C, Brown D, Chang DT, Cloyd J, Covey AM, Hawkins W, Iyer R, Jacob R, Karachristos A, Kelley RK, Kim R, Palta M, Park JO, Sahai V, Schefter T, Sicklick JK, Singh G, Sohal D, Stein S, Tian GG, Vauthey JN, Venook AP, Hammond LJ, Darlow SD. Benson AB, et al. Among authors: alberts sr. J Natl Compr Canc Netw. 2019 Apr 1;17(4):302-310. doi: 10.6004/jnccn.2019.0019. J Natl Compr Canc Netw. 2019. PMID: 30959462
Timing means everything, maybe.
Alberts SR. Alberts SR. Ann Surg Oncol. 2009 Sep;16(9):2431-2. doi: 10.1245/s10434-009-0577-3. Epub 2009 Jun 23. Ann Surg Oncol. 2009. PMID: 19548032 Free PMC article. No abstract available.
North Central Cancer Treatment Group--achievements and perspectives.
Grothey A, Adjei AA, Alberts SR, Perez EA, Jaeckle KA, Loprinzi CL, Sargent DJ, Sloan JA, Buckner JC; North Central Cancer Treatment Group. Grothey A, et al. Among authors: alberts sr. Semin Oncol. 2008 Oct;35(5):530-44. doi: 10.1053/j.seminoncol.2008.07.006. Semin Oncol. 2008. PMID: 18929151 Free PMC article. Review.
Different prognostic values of KRAS exon 2 submutations and BRAF V600E mutation in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: an ACCENT/IDEA pooled analysis of seven trials.
Taieb J, Sinicrope FA, Pederson L, Lonardi S, Alberts SR, George TJ, Yothers G, Van Cutsem E, Saltz L, Ogino S, Kerr R, Yoshino T, Goldberg RM, André T, Laurent-Puig P, Shi Q. Taieb J, et al. Among authors: alberts sr. Ann Oncol. 2023 Nov;34(11):1025-1034. doi: 10.1016/j.annonc.2023.08.006. Epub 2023 Aug 23. Ann Oncol. 2023. PMID: 37619846 Free PMC article.
220 results